SCRIBE

EUIPO EUIPO 2023 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark SCRIBE was filed as Word mark on 04/06/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/15/2023. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 018859037
Application date April 6, 2023
Publication date May 17, 2023
Entry date May 15, 2023
Expiration date April 6, 2033

Trademark owner

1150 Marina Village Pkwy
94501 Alameda
US

Trademark representatives

Bischoffsheimlaan 15 1000 Brussels BE

goods and services

5 pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics; gene therapy products, namely, biological preparations based on engineered cells for medical use in immuno oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, including neurological disorders, huntington's disease, amyotrophic lateral sclerosis (als), front temporal dementia, pain, alzheimer's, parkinson's, ataxia, autism, epilepsy, pain; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, including cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders
44 molecular diagnostic services for medical purposes; medical diagnostic testing services in the field of human disease and human medical conditions

ID: 11018859037